Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Replacement: Director/PDMR Shareholding

20 May 2016 14:33

RNS Number : 9068Y
Cello Group plc
20 May 2016
 

The following amendments have been made to the 'Director's Dealing' announcement released on 20 May 2016 at 1.30 pm under RNS No 9009Y.

 

The number of ordinary shares sold by Mark Bentley was 77,511, as opposed to 77,476 as previously announced. Accordingly, Mr Bentley's retained interest in ordinary shares is now 337,968, as opposed to 338,003 as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 May 2016

Cello Group plc

("Cello" or the "Company")

 

Director's dealing

 

The Company has been notified that on 20 May 2016 the following directors of the Company exercised options under the PSP Option Scheme 2010 ("PSP") and the Approved Share Option Plan 2009 ("Approved") in order to increase their stakes in the Company.

Details of the exercise of options by the directors are set out below:

Director

Option Scheme

No of options held prior to exercise

No of options exercised

Exercise Price

No of options held post exercise

Mark Scott

PSP

1,550,000

770,000

10p

780,000

Mark Scott

Approved

72,000

72,000

31.5p

-

Mark Bentley

PSP

605,000

130,000

10p

475,000

Stephen Highley

PSP

420,000

50,000

10p

370,000

 

Following the exercise of these options the directors made the following sale of ordinary shares of 10 pence each in the Company ("Ordinary Shares"), these sales were made to cover exercise, tax and national insurance costs:

Director

No of ordinary shares prior to exercise and sale

No of ordinary shares sold

Sale Price

Retained interest in ordinary shares

% of issued share capital (as enlarged by the issue of options)

Mark Scott

964,379

486,204

97.2p

1,320,175

1.52%

Mark Bentley

285,479

77,511

97.2p

337,968

0.39%

Stephen Highley

2,046,889

22,285

97.2p

2,074,604

2.39%

 

 Contacts:

 

 Cello Group 020 7812 8460

 Mark Scott, Chief Executive

 Mark Bentley, Finance Director

 

 Cenkos Securities 0207 397 8900

 Bobbie Hilliam

 Harry Pardoe

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFVEDIIFIR
Date   Source Headline
5th Jun 20181:24 pmRNSBlock listing Interim Review
29th May 20183:45 pmRNSDirector/PDMR Dealings and Total Voting Rights
9th May 20181:14 pmRNSResult of AGM
9th May 20187:00 amRNSAGM Statement
30th Apr 20182:58 pmRNSTotal Voting Rights
26th Apr 20189:45 amRNSChange of Name
25th Apr 20184:45 pmRNSChange of Name update
23rd Apr 201810:28 amRNSChange of name to Cello Health Group plc
16th Apr 20189:30 amRNSAnnual Report and Notice of AGM
22nd Mar 20187:00 amRNSFinal Results
27th Feb 20183:38 pmRNSTotal Voting Rights
18th Jan 20187:00 amRNSPre Close Trading Statement
23rd Nov 20173:54 pmRNSHolding(s) in Company
31st Oct 201711:16 amRNSTotal Voting Rights
26th Oct 20172:37 pmRNSDirector/PDMR Shareholding
29th Sep 20173:43 pmRNSGrant of Options
27th Sep 20174:59 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:05 pmRNSDirector/PDMR Shareholding
20th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 201711:52 amRNSAdditional Block Listing of Ordinary Shares
20th Sep 20177:00 amRNSInterim Results
31st Aug 20173:19 pmRNSTotal Voting Rights
31st Jul 20173:06 pmRNSTotal Voting Rights
19th Jul 20177:00 amRNSPre Close Trading Statement
18th Jul 20177:00 amRNSAcquisition of Advantage Healthcare Inc
30th Jun 201712:31 pmRNSTotal Voting Rights
23rd Jun 201712:23 pmRNSHolding(s) in Company
14th Jun 201711:33 amRNSDirector/PDMR Shareholding
31st May 201710:27 amRNSTotal Voting Rights
18th May 20172:13 pmRNSHolding(s) in Company
10th May 20175:18 pmRNSHolding(s) in Company
9th May 20172:55 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Statement
2nd May 20173:15 pmRNSIssue of Equity
13th Apr 20172:40 pmRNSAnnual Report and notice of Annual General Meeting
4th Apr 20175:44 pmRNSBlock listing Interim Review
31st Mar 201710:43 amRNSTotal Voting Rights
28th Mar 20173:03 pmRNSHolding(s) in Company
22nd Mar 20177:00 amRNSPreliminary Results
21st Feb 20171:30 pmRNSHolding(s) in Company
20th Feb 20173:19 pmRNSHolding(s) in Company
20th Feb 20179:29 amRNSTotal Voting Rights
17th Feb 201710:40 amRNSResult of General Meeting
1st Feb 20177:00 amRNSPlacing & Acquisition of Defined Health
19th Jan 20177:00 amRNSPre close trading statement
31st Oct 20163:58 pmRNSTotal Voting Rights
28th Oct 201611:37 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSDirectorate Change
5th Oct 20164:32 pmRNSDirector/PDMR Shareholding
23rd Sep 20165:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.